Traws Pharma (TRAW) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Traws Pharma (TRAW) over the last 13 years, with Q3 2024 value amounting to $72000.0.
- Traws Pharma's Accumulated Depreciation & Amortization rose 2413.79% to $72000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $72000.0, marking a year-over-year increase of 2413.79%. This contributed to the annual value of $62000.0 for FY2023, which is 3478.26% up from last year.
- Per Traws Pharma's latest filing, its Accumulated Depreciation & Amortization stood at $72000.0 for Q3 2024, which was up 2413.79% from $70000.0 recorded in Q2 2024.
- Over the past 5 years, Traws Pharma's Accumulated Depreciation & Amortization peaked at $2.2 million during Q3 2020, and registered a low of $18000.0 during Q4 2020.
- Its 5-year average for Accumulated Depreciation & Amortization is $391157.9, with a median of $49000.0 in 2023.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 9919.39% in 2020, then soared by 7777.78% in 2021.
- Quarter analysis of 5 years shows Traws Pharma's Accumulated Depreciation & Amortization stood at $18000.0 in 2020, then soared by 77.78% to $32000.0 in 2021, then skyrocketed by 43.75% to $46000.0 in 2022, then soared by 34.78% to $62000.0 in 2023, then increased by 16.13% to $72000.0 in 2024.
- Its Accumulated Depreciation & Amortization was $72000.0 in Q3 2024, compared to $70000.0 in Q2 2024 and $66000.0 in Q1 2024.